196 related articles for article (PubMed ID: 29930723)
1. DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells.
Laengle J; Stift J; Bilecz A; Wolf B; Beer A; Hegedus B; Stremitzer S; Starlinger P; Tamandl D; Pils D; Bergmann M
Theranostics; 2018; 8(12):3198-3213. PubMed ID: 29930723
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
3. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
Yamashita S; Odisio BC; Huang SY; Kopetz SE; Ahrar K; Chun YS; Conrad C; Aloia TA; Gupta S; Harmoush S; Hicks ME; Vauthey JN
Eur J Surg Oncol; 2017 Jun; 43(6):1040-1049. PubMed ID: 28187878
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
Mazzaferro V; Coppa J; Carrabba MG; Rivoltini L; Schiavo M; Regalia E; Mariani L; Camerini T; Marchianò A; Andreola S; Camerini R; Corsi M; Lewis JJ; Srivastava PK; Parmiani G
Clin Cancer Res; 2003 Aug; 9(9):3235-45. PubMed ID: 12960108
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
6. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
[TBL] [Abstract][Full Text] [Related]
7. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
[TBL] [Abstract][Full Text] [Related]
8. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
[TBL] [Abstract][Full Text] [Related]
10. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
Stift J; Graf A; Schwarz C; Tamandl D; Starlinger P; Herac M; Beer A; Wrba F; Bodingbauer M; Kaczirek K; Stremitzer S
Eur J Surg Oncol; 2018 Jan; 44(1):139-147. PubMed ID: 29203074
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
12. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
[TBL] [Abstract][Full Text] [Related]
13. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
14. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
15. Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.
Neofytou K; Pikoulis E; Petrou A; Agrogiannis G; Petrides C; Papakonstandinou I; Papalambros A; Aggelou A; Kavatzas N; Liakakos T; Felekouras E
Sci Rep; 2017 May; 7(1):2058. PubMed ID: 28515480
[TBL] [Abstract][Full Text] [Related]
16. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
[TBL] [Abstract][Full Text] [Related]
17. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
19. Is complete liver resection without resection of synchronous lung metastases justified?
Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
[TBL] [Abstract][Full Text] [Related]
20. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
